PMN

PMN

USD

ProMIS Neurosciences Inc. Common Shares (ON)

$0.406-0.004 (-0.878%)

Precio en Tiempo Real

Healthcare
Biotecnología
Canadá

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.410

Máximo

$0.419

Mínimo

$0.401

Volumen

0.28M

Fundamentos de la Empresa

Capitalización de Mercado

21.9M

Industria

Biotecnología

País

Canada

Estadísticas de Negociación

Volumen Promedio

1.51M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.38Actual $0.406Máximo $1.59

Noticias Relacionadas

GlobeNewswire

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cambridge, Massachusetts, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (NASDAQ:PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other

Ver más
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
GlobeNewswire

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

Appointment reinforces ProMIS Neurosciences' strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer's program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE

Ver más
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.